Triclofos

Evidence Level: N/A Predicted Indications: 0

Table of Contents

  1. Triclofos
    1. Pharmacist Assessment Report
    2. Triclofos
    3. Quick Overview
    4. India Market Information
    5. Safety Considerations
    6. Disclaimer

Pharmacist Assessment Report

Triclofos

Quick Overview

Item Content
Original Indication Not recorded in the local data
India Market Status Listed in a compiled Indian medicine price dataset (18 of 18) – CDSCO approval status is not included in this data
Number of Listed Products 18 (valid: 18)

India Market Information

Triclofos is marketed in India with 18 valid single-ingredient registrations. Indication text is blank on all of them. Five examples:

Authorization Number Product Name Dosage Form Approved Indication
174194 Pedicalm Oral Solution Oral solution, 30 ml bottle Not stated
174456 Pedirest Syrup Syrup, 30 ml bottle Not stated
223755 Tricloslep Drop Drop, 15 ml packet Not stated
173611 Pedicloryl Oral Solution Oral solution, 30 ml bottle Not stated
227201 Trolis 500mg Oral Suspension Oral suspension, 30 ml bottle Not stated

Safety Considerations

Please refer to the package insert for safety information. Warnings and contraindications could not be retrieved for this report, and no drug-interaction records were found.

It also notes that sedation could confound neurological assessment in acute encephalopathy.


Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.



This site uses Just the Docs, a documentation theme for Jekyll.